Erratum: Inhibition of ER stress-mediated apoptosis in macrophages by nuclear-cytoplasmic relocalization of eEF1A by the HIV-1 Nef protein (Cell Death and Disease (2012) 3 (e292) 10.1038/cddis.2012.32);Inhibition of ER stress-mediated apoptosis in macrophages by nuclear-cytoplasmic relocalization of eEF1A by the HIV-1 Nef protein

Cell Death and Disease

Volumn 3, Issue 4, 2012, Pages

  Abbas, W ^a   Khan, K A ^a   Tripathy, M K ^a   Dichamp, I ^a   Keita, M ^a   Rohr, O ^b   Herbein, G ^a  

^a University of Franche Comte ^*  (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Apoptosis; Cytochrome c; eEF1A; Macrophage; Nef; tRNA

Indexed keywords

BREFELDIN A; CYTOCHROME C; ELONGATION FACTOR 1; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA; NEF PROTEIN; UNCLASSIFIED DRUG; CASPASE 3; CASPASE 9; EEF1A1 PROTEIN, HUMAN; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TRANSFER RNA; XPOT PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENDOPLASMIC RETICULUM STRESS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TRANSPORT; ACTIVE TRANSPORT; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MITOCHONDRION; PROTEIN ANALYSIS; RNA INTERFERENCE;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; BREFELDIN A; CASPASE 3; CASPASE 9; CELLS, CULTURED; CYTOCHROMES C; ENDOPLASMIC RETICULUM STRESS; HIV-1; HUMANS; MACROPHAGES; MITOCHONDRIA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PEPTIDE ELONGATION FACTOR 1; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, TRANSFER;

EID: 84862065099     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.104     Document Type: Erratum

References (21)

1. Noteborn MH, de Boer GF, van Roozelaar DJ, Karreman C, Kranenburg O, Vos JG et al. Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol 1991; 65: 3131-3139.
2. Noteborn MH, Koch G. Chicken anaemia virus infection: molecular basis of pathogenicity. Avian Pathol 1995; 24: 11-31.
3. Noteborn MH, Todd D, Verschueren CA, de Gauw HW, Curran WL, Veldkamp S et al. A single chicken anemia virus protein induces apoptosis. J Virol 1994; 68: 346-351.
4. Tavassoli M, Guelen L, Luxon BA, Gaken J. Apoptin: specific killer of tumor cells? Apoptosis 2005; 10: 717-724. (Pubitemid 41187071)
5. Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, Voskamp P et al. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol 2008; 48: 143-169. (Pubitemid 351756360)
6. Pietersen AM, van der Eb MM, Rademaker HJ, van den Wollenberg DJ, Rabelink MJ, Kuppen PJ et al. Specific tumor-cell killing with adenovirus vectors containing the apoptin gene. Gene Ther 1999; 6: 882-892. (Pubitemid 29243663)
7. Danen-Van Oorschot AA, Zhang YH, Leliveld SR, Rohn JL, Seelen MC, Bolk MW et al. Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem 2003; 278: 27729-27736. (Pubitemid 36899962)
8. Poon IK, Oro C, Dias MM, Zhang J, Jans DA. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res 2005; 65: 7059-7064. (Pubitemid 41161232)
9. Rohn JL, Zhang YH, Aalbers RI, Otto N, Den Hertog J, Henriquez NV et al. A tumor-specific kinase activity regulates the viral death protein Apoptin. J Biol Chem 2002; 277: 50820-50827. (Pubitemid 36042247)
10. Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F, Tavassoli M. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 2004; 23: 1153-1165. (Pubitemid 38269969)
11. Zhang YH, Kooistra K, Pietersen A, Rohn JL, Noteborn MH. Activation of the tumor-specific death effector apoptin and its kinase by an N-terminal determinant of simian virus 40 large T antigen. J Virol 2004; 78: 9965-9976. (Pubitemid 39187115)
12. Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ, Noteborn MH. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res 1995; 55: 486-489.
13. Klanrit P, Flinterman MB, Odell EW, Melino G, Killick R, Norris JS et al. Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptin. Cell Cycle 2008; 7: 205-215. (Pubitemid 351366521)
14. Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci 2005; 118: 4485-4493. (Pubitemid 41556346)
15. Liu X, Zeidan YH, Elojeimy S, Holman DH, El-Zawahry AM, Guo GW et al. Involvement of sphingolipids in apoptin-induced cell killing. Mol Ther 2006; 14: 627-636. (Pubitemid 44480757)
16. Zhang YH, Leliveld SR, Kooistra K, Molenaar C, Rohn JL, Tanke HJ et al. Recombinant Apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in a normal-cellspecific fashion. Exp Cell Res 2003; 289: 36-46. (Pubitemid 36993835)
17. Jiang J, Cole D, Westwood N, Macpherson L, Farzaneh F, Mufti G et al. Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptin. Cancer Res 2010; 70: 7242-7252.
18. Maddika S, Panigrahi S, Wiechec E, Wesselborg S, Fischer U, Schulze-Osthoff K et al. Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity. Mol Cell Biol 2009; 29: 1235-1248.
19. Sauvage V, Cheval J, Foulongne V, Gouilh MA, Pariente K, Manuguerra JC et al. Identification of the first human gyrovirus, a virus related to chicken anemia virus. J Virol 2011; 85: 7948-7950.
20. Flinterman M, Farzaneh F, Habib N, Malik F, Gaken J, Tavassoli M. Delivery of therapeutic proteins as secretable TAT fusion products. Mol Ther 2009; 17: 334-342.
21. Argiris K, Panethymitaki C, Tavassoli M. Naturally occurring, tumor-specific, therapeutic proteins. Exp Biol Med (Maywood) 2011; 236: 524-536.